TGS


MHRA authorises gemcitabine delivery system for adults with BCG-unresponsive high-risk non-muscle invasive bladder cancer

MHRA authorises gemcitabine delivery system for adults with BCG-unresponsive high-risk non-muscle invasive bladder cancer

https://www.gov.uk/government/news/mhra-authorises-gemcitabine-delivery-system-for-adults-with-bcg-unresponsive-high-risk-non-muscle-invasive-bladder-cancer

seen at 14:56, 1 July in News and communications.

© Crown 2013